Clinical trial
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
NCT01912196
Study timeline
Study start (unknown)2013-10-01Date precision: month
Registry last updated2016-03-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Major Depressive Disorder (MDD)unresolved
Interventions
Sponsors & collaborators
MSI Methylation Sciences, Inc.lead sponsor
Mapped research locations
HoustonTexas, United States2AustinTexas, United States2New YorkNew York, United States1Los AngelesCalifornia, United States1DallasTexas, United States1AtlantaGeorgia, United States1BirminghamAlabama, United States1PortlandOregon, United States1JacksonvilleFlorida, United States1OrlandoFlorida, United States1RochesterNew York, United States1Las VegasNevada, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01912196 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.